FFF Enterprises Launches 2012-13 MyFluVaccine Ordering With Expanded Portfolio
Customers Are Encouraged to Order Early to Receive Select Manufacturer Discounts and Rebates, and to Secure Their Preferred Delivery Dates
(firmenpresse) - TEMECULA, CA -- (Marketwire) -- 12/19/11 -- FFF Enterprises, Inc., the nation's largest and most trusted distributor of flu vaccine, announced today that its expanded portfolio of flu vaccine for the 2012-13 flu season is now available for purchase. Customers who order early can choose their preferred delivery dates to match their vaccination schedule.
For those who think the flu vaccine is a one-size-fits-all product, think again. FFF's expansive portfolio includes vaccines for different age groups and preferences, including the high-dose vaccine for those 65 years of age and older; the new intradermal microinjection system vaccine; and FluMist intranasal spray vaccine. FFF is a distributor for Fluvirin® manufactured by Novartis Vaccines; Fluzone® manufactured by sanofi pasteur; FluLaval® and Fluarix® manufactured by GlaxoSmith Kline; FluMist® manufactured by Medimmune; and Afluria® from Merck/CSL.
For healthcare providers, fighting seasonal flu begins with ordering flu vaccines. Having access to a trustworthy distribution system for flu vaccines is crucial. In 2005, FFF launched its innovative MyFluVaccine program () to help streamline the flu vaccine distribution process. Unlike the traditional influenza vaccine distribution system, MyFluVaccine gives healthcare providers more product choice, the convenience of choosing the exact date they would like their flu vaccine to arrive, and the safety of a secure supply chain when preparing for their vaccination season.
In addition to easy online ordering, the MyFluVaccine website provides news, updates, resources and clinic planning tools. There are special informative sections for consumers and employer groups, as well as providers. FFF has also produced a "Flu Vaccine Myths & Facts" brochure that is downloadable as a PDF from the website, or as a printed booklet that healthcare physicians can order for their patients.
FFF's expanded portfolio offers flu vaccines for every demographic group -- from pediatrics to seniors -- and its early ordering announcement is timely: The expanded vaccination guidelines from the Centers for Disease Control and Prevention (CDC) advise everyone aged 6 months and older to get an annual flu vaccine.
Temecula-based FFF Enterprises is the nation's largest and most trusted distributor of the flu vaccine, plasma products, and other biopharmaceuticals. Founded in 1988, FFF is now in its 24th year with more than a billion dollars in annual sales and a flawless safety track record. FFF has taken a leadership position in regards to supply chain safety and innovation, setting new standards and pioneering industry firsts. FFF's commitment to Guaranteed Channel Integrity™ ensures that products are purchased only from the manufacturer and shipped only to healthcare providers, with additional steps taken to safely store, handle and ship products to ensure patient safety is never compromised. FFF's proprietary systems, Verified Electronic Pedigree™ and Lot-Track™, provide verification of this secure channel, and FFF's MyFluVaccine () and VaxAmerica () are revolutionary vaccination programs that have added a new level of safety, convenience and reliability to both healthcare providers and consumers.
Now in its fifth year, MyFluVaccine (), a program of FFF Enterprises, was launched to help streamline the flu vaccine distribution process. MyFluVaccine gives healthcare providers choice, convenience and the safety of a secure supply chain when ordering flu vaccine. In addition to easy online ordering for vaccines, the MyFluVaccine website provides news, updates, resources and clinic planning tools for consumers and employer groups, as well as providers.
Contact:
Sheryl Perez:
(951) 296-2500, ext 1357
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 19.12.2011 - 14:00 Uhr
Sprache: Deutsch
News-ID 98248
Anzahl Zeichen: 0
contact information:
Town:
TEMECULA, CA
Kategorie:
Biotech
Diese Pressemitteilung wurde bisher 235 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"FFF Enterprises Launches 2012-13 MyFluVaccine Ordering With Expanded Portfolio"
steht unter der journalistisch-redaktionellen Verantwortung von
FFF Enterprises (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
